FDA Approves Nintedanib for SSc-ILD, But Temper Your Expectations
• By Michael Putman, MD
- Tweet
• By Michael Putman, MD
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.
Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.